⌘K

Home/Filings/4/0000950170-24-096499

4//SEC Filing

Lind Kevin Robert 4

Accession 0000950170-24-096499

CIK 0001832168other

View on SEC.gov Company Profile

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 6:03 PM ET

Size

10.2 KB

Accession

0000950170-24-096499

Insider Transaction Report

Form 4

Period: 2024-08-12

Longboard Pharmaceuticals, Inc.LBPH

Lind Kevin Robert

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
2024-08-12$3.12/sh+80,265$250,684→ 428,715 total
Exercise/Conversion
Common Stock
2024-08-12$4.20/sh+2,217$9,311→ 430,932 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-08-12−80,265→ 268,185 total
Exercise: $3.12Exp: 2030-10-26→ Common Stock (80,265 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2024-08-12−2,217→ 192,783 total
Exercise: $4.20Exp: 2032-02-08→ Common Stock (2,217 underlying)

Footnotes (2)

[F1]The shares subject to the stock option vest and become exercisable in 24 equal monthly installments commencing November 27, 2022.
[F2]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Longboard Pharmaceuticals, Inc.

CIK 0001832168

Entity typeother

Related Parties

1

filerCIK 0001677036

Filing Metadata

Form type: 4
Filed: Aug 12, 8:00 PM ET
Accepted: Aug 13, 6:03 PM ET
Size: 10.2 KB

View on SEC.gov